Diagonal Bio AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
October 31, 2023 at 02:30 am
Diagonal Bio AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 0.781 million compared to SEK 1.29 million a year ago. Revenue was SEK 0.789 million compared to SEK 1.29 million a year ago. Net loss was SEK 2.66 million compared to SEK 3.76 million a year ago. Basic loss per share from continuing operations was SEK 0.08.
For the nine months, sales was SEK 2.72 million compared to SEK 2.86 million a year ago. Revenue was SEK 2.74 million compared to SEK 2.89 million a year ago. Net loss was SEK 9.15 million compared to SEK 11.98 million a year ago. Basic loss per share from continuing operations was SEK 0.26.